European Countries Order 1.25 Million Whole-Virus COVID-19 Vaccines

France-based Valneva SE today confirmed the signing of the amendment to its Advance Purchase Agreement (APA) with the European Commission (EC). Under this amendment, the EC Member States’ purchases of VLA2001, Valneva’s inactivated whole-virus COVID-19 vaccine, consist of 1.25 million doses in 2022.

VLA2001 is the only whole virus, inactivated, adjuvanted COVID-19 vaccine that has received marketing authorization in Europe.

The APA includes an option to purchase an equivalent quantity later this year for delivery in 2022.

Valneva stated in a media release on August 1, 2022, it expects to deliver the first vaccine doses to participating Germany, Austria, Denmark, Finland, and Bulgaria in the coming weeks.

In Europe, the European Medicines Agency has authorized six COVID-19 vaccines and is reviewing four other vaccines.

Regarding overall vaccinations, the European Centre for Disease Prevention and Control reported on July 21, 2022, that about 73% of adult Europeans had completed their primary vaccination course, while about 5.1% have been fully 'boosted' with a fourth dose.

Note: Valneva's press statement was manually curated for mobile readership.